Healthcare News • Pharma Industry News FDA approves Pfizer's NGENLA™, a long-acting once-weekly treatment for pediatric growth hormone deficiency 3 years ago
Pharma Industry News June 30 2023 – 9 highly anticipated FDA decisions in second half of 2023 3 years ago
Healthcare News • Pharma Industry News New approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction 3 years ago
Healthcare News • Pharma Industry News Proteins predict significant step toward development of diabetes 3 years ago
Healthcare News • Pharma Industry News Bayer's new pharmaceutical R&D strategy to accelerate breakthrough innovations 3 years ago
Healthcare News • Pharma Industry News FDA accepts Pfizer's application for hemophilia B gene therapy fidanacogene elaparvovec 3 years ago
Healthcare News • Pharma Industry News Higher doses of oral semaglutide improves blood sugar control and weight loss 3 years ago
Healthcare News • Pharma Industry News FDA approves Pfizer's LITFULO™ (ritlecitinib) for adults and adolescents with severe alopecia areata 3 years ago